#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15294	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2027	745.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1442	1442	C	938	C	884	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3489	796.0	0	.	n	.	0	T695C	SNP	695	695	T	1046	1046	C	817	C	755	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3489	796.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1688	1688	A	926	A,G	871,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3489	796.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2322	2322	C	912	C,A	840,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3489	796.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2396	2396	A	890	A	833	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3489	796.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2948	2948	C	868	C,T	811,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3489	796.0	0	HET	.	.	.	C933T	.	933	933	C	1284	1284	C	894	C,T	644,181	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2020	folP	855	855	100.0	folP.l15.c4.ctg.1	1608	125.4	1	SNP	p	R229S	0	.	.	685	687	CGC	1103	1105	CGC	210;213;211	C;G;C	194;194;192	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5192	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3446	150.4	1	SNP	p	S91F	0	.	.	271	273	TCC	651	653	TCC	190;193;192	T;C;C	175;178;175	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5192	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3446	150.4	1	SNP	p	D95N	0	.	.	283	285	GAC	663	665	GAC	180;179;181	G;A;C	168;167;169	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5192	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3446	150.4	1	SNP	p	D95G	0	.	.	283	285	GAC	663	665	GAC	180;179;181	G;A;C	168;167;169	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1646	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1481	110.9	1	SNP	p	G45D	1	.	.	133	135	GAC	515	517	GAC	204;205;206	G;A,G;C	194;189,2;195	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	840	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1093	76.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5138	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3000	170.9	1	SNP	p	D86N	0	.	.	256	258	GAC	582	584	GAC	222;223;224	G;A;C	210;211;211	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5138	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3000	170.9	1	SNP	p	S88P	0	.	.	262	264	TCC	588	590	TCC	221;220;222	T;C;C	204;205;208	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4132	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2619	156.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1611	1613	GGC	224;218;218	G;G;C,A	208;201;200,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1342	1344	GCA	225;227;229	G;C;A	206;209;211	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1345	1347	ATC	223;225;225	A;T;C	208;209;212	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1357	1359	GTG	226;226;225	G;T;G	209;210;207	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1357	1359	GTG	226;226;225	G;T;G	209;210;207	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1861	1863	ACC	196;197;196	A;C;C	178;182;181	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1915	1917	GCG	191;192;193	G;C;G	170;153;160	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1915	1917	GCG	191;192;193	G;C;G	170;153;160	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2038	2040	GGC	195;198;199	G,A;G;C	178,1;179;180	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2047	2049	GGC	201;198;198	G;G;C	179;177;175	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3944	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2456	160.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2065	2067	CTG	185;186;188	C,G;T;GCCC,GCCCC	139,5;126;139,2	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5688	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3034	186.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1604	1606	CCG	189;190;189	C;C;G	164;171;168	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2132	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1929	110.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	370	372	GGC	122;121;123	G;G;C	111;109;113	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2132	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1929	110.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	552	552	C	158	C	143	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	T18M	NONSYN	52	54	ACG	441	443	ATG	252;253;254	A;T,C;G,C	238;238,1;238,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	654	656	AGC	238;238;241	A;G;C	215;215;218	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	816	818	CAA	242;239;239	C,G;A,G;A	226,1;223,1;221	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1023	1025	GAT	197;196;195	G;A;T	191;191;188	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1026	1028	GAT	194;193;194	G,A;A,G;T	188,1;185,1;189	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	V215T	NONSYN	643	645	GTT	1032	1034	ACT	194;198;198	A,T;C,A;T	188,1;192,1;192	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	I218T	NONSYN	652	654	ATC	1041	1043	ACC	207;206;208	A;C,T;C	195;195,1;200	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1158	1160	ACG	238;237;239	A;C;G	220;219;222	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1164	1166	GTT	235;239;236	G;T;T	218;219;220	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1278	1280	AAC	247;247;246	A;A;C,A	232;231;231,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2882	porB1b	1047	1047	98.38	porB1b.l6.c4.ctg.1	1703	168.6	1	SNP	p	G120K	0	.	.	358	360	GGC	747	749	GGC	232;230;232	G;G;C	218;212;215	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	11300	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4897	230.2	0	.	p	.	0	K1092R	NONSYN	3274	3276	AAA	3615	3617	AGA	223;220;221	A;G;A	208;207;209	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1270	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	982	127.9	1	SNP	p	V57M	1	.	.	169	171	ATG	466	468	ATG	259;260;262	A;T;G	245;244;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
